COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions, Inc. Starts New Year With Inclusion in EPA Lists G, L, and M

27/12/2017 - 15:30

BEVERLY HILLS, Calif., Dec. 27, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]

American Health Council Names Carl Roland, PharmD, MS to Industry Board

27/12/2017 - 15:04

NEW YORK, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Carl Roland, Senior Director at Pfizer, has been selected to join the Industry Board at the American Health Council. He will be sharing his knowledge and expertise in Clinical [...]

Actinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial Continue

27/12/2017 - 15:00

Actinium expects enhanced awareness of Iomab-B at ASH annual meeting and expanded site activity to enable completion of trial enrollment by end of 2018, in-line with prior forecast NEW YORK, Dec. 27, 2017 (GLOBE [...]

UPDATE -- Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer

27/12/2017 - 14:56

Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company’s Strategy, Vision and Execution WALTHAM, Mass., Dec. 27, 2017 ( [...]

Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer

27/12/2017 - 14:30

Biopharmaceutical Industry Leader with Extensive Experience In Drug Development, Strategic Business Combinations and Commercialization to Lead The Company’s Strategy, Vision and Execution WALTHAM, Mass., Dec. 27, 2017 ( [...]

Agritek Holdings, Inc. Announces $1,000,000 Capital Infusion With Institutional Investor And Eliminates First $200,000 Of Existing Toxic Convertible Debt With Final $500,000 In Convertible Debt To Be Paid By Year End.

27/12/2017 - 14:30

LOS ANGELES, CA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]

Sarepta Therapeutics Announces Publication of Long-Term Pulmonary Function of Eteplirsen-Treated Patients Compared to Natural History of Duchenne Muscular Dystrophy in The Journal of Neuromuscular Diseases

27/12/2017 - 14:30

CAMBRIDGE, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

Athenex Receives Promising Innovative Medicine Designation from the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel

27/12/2017 - 14:00

BUFFALO, N.Y., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme

27/12/2017 - 14:00

CHARLOTTESVILLE, Va., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]

Innovation Pharmaceuticals Obtains Direct Evidence of Molecular Pathways Modulation in Tumors from First Patients in Kevetrin Ph2a Ovarian Cancer Trial

27/12/2017 - 13:30

BEVERLY, Mass., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce highly encouraging preliminary data [...]

Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron

27/12/2017 - 13:30

UTRECHT, The Netherlands, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), today announced [...]

Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission

27/12/2017 - 13:30

CARMIEL, Israel, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]

ProQR Announces Extraordinary General Meeting of Shareholders

27/12/2017 - 13:00

LEIDEN, the Netherlands, Dec. 27, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.(Nasdaq: PRQR ), today announced that an Extraordinary General Meeting of Shareholders will be held on Monday, February 19, 2018, at 16: [...]

Blood donors step up, but more still needed

27/12/2017 - 13:00

OTTAWA, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Canadian Blood Services has seen a notable increase in donations since Dec. 18 when it issued an urgent call for eligible donors to fill 35,000 open appointments by Jan. 6. [...]

VBL Therapeutics Announces First Patient in Pivotal Phase 3 Study of VB-111 in Platinum Resistant Ovarian Cancer in Collaboration with the GOG Foundation, Inc.

27/12/2017 - 13:00

TEL AVIV, Israel, Dec. 27, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ) today announced the study initiation and first patient in its Phase 3 pivotal registration trial, OVAL, studying its lead candidate VB [...]

Medigus Announces First MUSE(TM) Procedure for the Treatment of GERD Performed in Israel at Shaare-Zedek Medical Center

27/12/2017 - 13:00

OMER, Israel, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]

Novo Nordisk A/S: Share repurchase programme

27/12/2017 - 11:43

Bagsværd, Denmark, 27 December 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Orion Corporation: Managers' transactions - Westerlund Riikka

27/12/2017 - 08:46

ORION CORPORATION MANAGERS' TRANSACTIONS 27 DECEMBER 2017 at 9.45 EET Orion Corporation: Managers' transactions - Westerlund Riikka Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]

Herantis Pharma expands on timeline for Lymfactin studies

27/12/2017 - 08:01

Herantis Pharma expands on timeline for Lymfactin® studies Herantis Pharma Plc Company release 27 December 2017 at 9:00 am Herantis Pharma Plc's ("Herantis") announces a slight delay in completing patient recruitment in [...]